Published in
Elsevier, Lancet Haematology, 7(7), p. e511-e522, 2020
DOI: 10.1016/s2352-3026(20)30120-4
Links
Tools
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial
Journal article published in 2020 by
Nagesh Kalakonda,
Marie Maerevoet,
Federica Cavallo,
George Follows,
Andre Goy,
Joost S. P. Vermaat 
,
Olivier Casasnovas ,
Nada Hamad ,
Josée M. Zijlstra,
Sameer Bakhshi,
Reda Bouabdallah,
Sylvain Choquet,
Ronit Gurion,
Brian Hill,
Ulrich Jaeger
and other authors.
,
Olivier Casasnovas ,
Nada Hamad ,
Josée M. Zijlstra,
Sameer Bakhshi,
Reda Bouabdallah,
Sylvain Choquet,
Ronit Gurion,
Brian Hill,
Ulrich Jaeger
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 